Tag Archive for: Cybin

Interview with Doug Drysdale, CEO, Cybin Inc

Doug talks about the company’s mission to revolutionize mental healthcare, how Cybin is delivering powerful and effective therapies, and why being the first psychedelic-based company to list on the New York Stock Exchange was a natural fit. Cybin can be found on the NYSE under the ticker symbol $CYBN.
Cybin Receives Conditional Approval to Trade on NYSE American

Cybin Receives Conditional Approval to Trade on NYSE American

And in other psychedelic stock news, Origin Therapeutics launches to make equity investments in emerging psychedelics-related companies.
Psychedelic Business Spotlight

Psychedelic Business Spotlight: July 9, 2021

This week in psychedelic business news: It’s all about partnerships and acquisitions designed to advance psychedelic therapies for depression, suicidal ideation, pain, and more.
Psilocybin depression treatment

Psychedelic Biotech Company Cybin Partners with Greenbrook to Develop Innovative Depression Treatment

, ,
Cybin CEO says agreement "serves as a major step toward establishing a national distribution network for future psychedelic therapies."